Prelude Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Prelude Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,072	Closed	-$1.95M	–	1212
2024 Q3	$1.95M	Buy	13,072 +8,342	+176%	+$1.13M	0.12%	232
2024 Q2	$645K	Buy	+4,730	New	+$644K	0.04%	435
2024 Q1	–	Sell	-6,500	Closed	-$819K	–	1309
2023 Q4	$819K	Sell	6,500 -700	-10%	-$69.8K	0.05%	346
2023 Q3	$674K	Buy	7,200 +800	+13%	+$74.8K	0.04%	390
2023 Q2	$571K	Sell	6,400 -1,600	-20%	-$139K	0.04%	420
2023 Q1	$858K	Buy	8,000 +700	+10%	+$80.1K	0.05%	336
2022 Q4	$892K	Buy	7,300 +2,300	+46%	+$267K	0.05%	415
2022 Q3	$516K	Sell	5,000 -1	-0%	-$95	0.02%	632
2022 Q2	$465K	Buy	5,001 +2,701	+117%	+$255K	0.01%	854
2022 Q1	$270K	Sell	2,300 -2,700	-54%	-$313K	0.01%	1115
2021 Q4	$673K	Buy	5,000 +2,996	+150%	+$446K	0.02%	839
2021 Q3	$319K	Buy	2,004 +4	+0.2%	+$547	0.01%	1110
2021 Q2	$263K	Buy	+2,000	New	+$267K	0.01%	1256
2020 Q4	–	Sell	-3,340	Closed	-$515K	–	1287
2020 Q3	$515K	Buy	+3,340	New	+$480K	0.02%	434

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Prelude Capital Management's ASND Position: Q4 2024 in Review

Prelude Capital Management sold out of Ascendis Pharma A/S (ASND) in Q4 2024, closing a stake of 13,072 shares — an estimated $1.95M sold.

Prelude Capital Management first reported a position in ASND in Q3 2020 and held it in 14 quarters. The position peaked at $1.95M in Q3 2024. 214 funds tracked by Wall St. Rank hold ASND as of Q4 2024.

Prelude Capital Management reported no remaining Ascendis Pharma A/S position as of Q4 2024 after selling out during the quarter.
Prelude Capital Management sold 13,072 Ascendis Pharma A/S shares in Q4 2024, an estimated $1.95M.
Prelude Capital Management first reported a position in Ascendis Pharma A/S in Q3 2020 and held it in 14 quarters.
Prelude Capital Management's Ascendis Pharma A/S position peaked at $1.95M in Q3 2024.
214 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2024.

Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.